As the saying goes, where there is smoke there's fire

[corpplanner]

Absolutely agree that they had to use Amphastar's insulin and lock it up immediately. However, MNKD will also have to secure a second source. When I was in a mid-size pharma, we had the brand of a pretty important product with a single source of the raw material so we really had to scramble to get a second source qualified and on line. Since Amphastar in is Europe, and we all see what is going on across the Pond, it behooves MNKD to get a second source qualified == in a different part of the world.